Skip to main content
OpenTrials

Clinical trial condition

Non-small Cell Lung Cancer

Explore clinical trials studying Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1,335 public trials 330 recruiting studies
Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer trial results

Completed

Navelbine And Radiotherapy in Locally Advanced Lung Cancer

NCT00887783

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Department of Oncology, Aalborg University Hospital Aalborg, Denmark
  • Department of Oncology, Aarhus University Hospital Aarhus, Denmark
  • Department of Oncology, Copenhagen University Hospital Herlev Herlev, Denmark
  • Department of Oncology, Odense University Hospital Odense, Denmark
View Trial Details
Completed

BPI-7711 Capsule in Patients With EGFR Mutation T790M Positive Non-small Cell Lung Cancer

NCT03386955

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Jiangsu Province Hospital Nanjing, Jiangsu, China
  • The First Affiliated Hospital of Suzhou University Suzhou, Jiangsu, China
View Trial Details
Completed

Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine

NCT03633110

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +39 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • John Wayne Cancer Institute - Providence Saint John's Health Center Santa Monica, California, United States
  • University of Colorado, Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

A Study of LY3023414 in Participants With Advanced Cancer

NCT01655225

Conditions
Adenoma, Advanced Cancer, Breast Diseases, +35 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Peggy and Charles Stephenson Oklahoma Cancer Center Oklahoma City, Oklahoma, United States
  • Penn Presbyterian Medical Center Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Phase 2 Study of Study of Tesevatinib in Subjects With NSCLC and Brain or Leptomeningeal Metastases

NCT02616393

Conditions
Brain Diseases, Brain Metastases, Brain Neoplasms, +18 more
Locations
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • USC Norris Oncology/Hematology Newport Beach Newport Beach, California, United States
  • John Wayne Cancer Institute Santa Monica, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
View Trial Details
Completed

Sorafenib/Erlotinib Versus Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)

NCT00600015

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Northeast Georgia Medical Center Gainesville, Georgia, United States
  • Wellstar Cancer Research Marietta, Georgia, United States
  • Kansas City Cancer Centers Overland Park, Kansas, United States
View all 16 locations
View Trial Details

Related conditions